IMNM Stock Price
Immunome, Inc.
IMNM stock price is $17.20 (-2.16% on the day), giving Immunome, Inc. a market cap of $2.03B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IMNM Stock Overview
- Price
- $17.20
- Previous close
- $17.58
- Open
- $17.35
- Market cap
- $2.03B
- P/E ratio
- -9.6
- 52-week range
- $13.53 - $30.06
- 1-year price target
- $35.20
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 40
About Immunome, Inc.
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises of AL102, a gamma secretase inhibitor which is in phase 3 clinical trial for the treatment of desmoid tumors; IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates which is in phase 1 clinical trial; and preclinical asset consist of IM-3050, a fibroblast activation protein targeted radioligand therapy. It also develops solid tumor ADC drug candidates which includes IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMNM | $17.20 | -2.2% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |